Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier)

Background: In anal cancer, there are no markers nor other laboratory indexes that can predict prognosis and guide clinical practice for patients treated with concurrent chemoradiation. In this study, we retrospectively investigated the influence of immune inflammation indicators on treatment outcom...

Descripción completa

Detalles Bibliográficos
Autores principales: Casadei-Gardini, Andrea, Montagnani, Francesco, Casadei, Chiara, Arcadipane, Francesca, Andrikou, Kalliopi, Aloi, Deborah, Prete, Alessandra Anna, Zampino, Maria Giulia, Argentiero, Antonella, Pugliese, Giuseppe, Martini, Stefania, Iorio, Giuseppe Carlo, Scartozzi, Mario, Mistrangelo, Massimiliano, Fornaro, Lorenzo, Cassoni, Paola, Marisi, Giorgia, Dell’Acqua, Veronica, Ravenda, Paola Simona, Lonardi, Sara, Silvestris, Nicola, De Bari, Berardino, Ricardi, Umberto, Cascinu, Stefano, Franco, Pierfrancesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506779/
https://www.ncbi.nlm.nih.gov/pubmed/31118786
http://dx.doi.org/10.2147/CMAR.S197349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506779/
https://www.ncbi.nlm.nih.gov/pubmed/31118786
http://dx.doi.org/10.2147/CMAR.S197349

Ejemplares similares